FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166789524> ?p ?o ?g. }

• W2166789524 endingPage "217" @default.
• W2166789524 startingPage "207" @default.
• W2166789524 abstract "OBJECTIVE: To evaluate the safety and efficacy of the thienopyridines in order to identify their current place in therapy for the treatment of acute coronary syndrome (ACS). DATA SOURCES: Literature was accessed through MEDLINE (1966-October 2010 week 1), EMBASE (1980–2010 week 40), and a bibliographic review of published articles using the search terms acute coronary syndrome, clopidogrel, and prasugrel. Articles were limited to clinical trials conducted in humans and published in the English language. STUDY SELECTION AND DATA EXTRACTION: Head-to-head clinical trials evaluating the safety and efficacy of the thienopyridines in patients with ACS were critically reviewed. Trials evaluating ticlopidine were excluded due to its limited clinical use. DATA SYNTHESIS: Thienopyridines are an integral part of the treatment of ACS. Prior to the approval of prasugrel, clopidogrel was considered the agent of choice due to safety concerns associated with ticlopidine. A randomized controlled trial comparing prasugrel and clopidogrel has demonstrated superior efficacy with prasugrel, and post hoc analyses suggest additional benefit with prasugrel is derived in patients with ST-segment elevation myocardial infarction and patients with diabetes. However, safety concerns exist linking prasugrel with an increased risk of bleeding, which diminishes its advantage in elderly patients, underweight patients, and those with a history of stroke. Pharmacokinetic and pharmacodynamic studies discussing differences in response variability, platelet inhibition, interactions with proton pump inhibitors, and genetic factors between the thienopyridines are numerous, although more clinical data are needed to determine clinical implications. CONCLUSIONS: Clinical trial data have suggested prasugrel is superior to clopidogrel at preventing ischemic events in patients with ACS undergoing percutaneous coronary intervention. However, this coincides with an increased risk of bleeding. Clinicians must carefully interpret the current evidence, including limitations in study design and pharmacologic differences between agents, in order to balance the risks and benefits as new data become available." @default.
• W2166789524 created "2016-06-24" @default.
• W2166789524 creator A5069119732 @default.
• W2166789524 creator A5077841286 @default.
• W2166789524 creator A5081418650 @default.
• W2166789524 date "2011-02-01" @default.
• W2166789524 modified "2023-09-25" @default.
• W2166789524 title "Thienopyridines in Acute Coronary Syndrome" @default.
• W2166789524 cites W1409766979 @default.
• W2166789524 cites W1756335821 @default.
• W2166789524 cites W1860735680 @default.
• W2166789524 cites W1970709974 @default.
• W2166789524 cites W1973881937 @default.
• W2166789524 cites W1976577625 @default.
• W2166789524 cites W1978913815 @default.
• W2166789524 cites W1985059672 @default.
• W2166789524 cites W1992350295 @default.
• W2166789524 cites W2000299291 @default.
• W2166789524 cites W2004298071 @default.
• W2166789524 cites W200979310 @default.
• W2166789524 cites W2038819610 @default.
• W2166789524 cites W2039164890 @default.
• W2166789524 cites W2054113896 @default.
• W2166789524 cites W2056384040 @default.
• W2166789524 cites W2065940829 @default.
• W2166789524 cites W2076472818 @default.
• W2166789524 cites W2081548185 @default.
• W2166789524 cites W2083038715 @default.
• W2166789524 cites W2085817407 @default.
• W2166789524 cites W2088308053 @default.
• W2166789524 cites W2099859959 @default.
• W2166789524 cites W2102040360 @default.
• W2166789524 cites W2102393690 @default.
• W2166789524 cites W2102968559 @default.
• W2166789524 cites W2105005467 @default.
• W2166789524 cites W2110108344 @default.
• W2166789524 cites W2110762472 @default.
• W2166789524 cites W2116457054 @default.
• W2166789524 cites W2121047179 @default.
• W2166789524 cites W2130350603 @default.
• W2166789524 cites W2138058610 @default.
• W2166789524 cites W2140501627 @default.
• W2166789524 cites W2140776066 @default.
• W2166789524 cites W2147746835 @default.
• W2166789524 cites W2148633205 @default.
• W2166789524 cites W2152376036 @default.
• W2166789524 cites W2152823642 @default.
• W2166789524 cites W2156506897 @default.
• W2166789524 cites W2161872374 @default.
• W2166789524 cites W2163961571 @default.
• W2166789524 cites W2167027711 @default.
• W2166789524 cites W2168693825 @default.
• W2166789524 cites W2169387542 @default.
• W2166789524 cites W2170949977 @default.
• W2166789524 cites W2170999274 @default.
• W2166789524 cites W2209519262 @default.
• W2166789524 cites W2327850977 @default.
• W2166789524 cites W2415338320 @default.
• W2166789524 cites W2614781785 @default.
• W2166789524 cites W2887768525 @default.
• W2166789524 cites W300595399 @default.
• W2166789524 cites W4205805944 @default.
• W2166789524 cites W4237556338 @default.
• W2166789524 cites W4249056819 @default.
• W2166789524 doi "https://doi.org/10.1345/aph.1p319" @default.
• W2166789524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21304037" @default.
• W2166789524 hasPublicationYear "2011" @default.
• W2166789524 type Work @default.
• W2166789524 sameAs 2166789524 @default.
• W2166789524 citedByCount "3" @default.
• W2166789524 countsByYear W21667895242012 @default.
• W2166789524 countsByYear W21667895242016 @default.
• W2166789524 countsByYear W21667895242022 @default.
• W2166789524 crossrefType "journal-article" @default.
• W2166789524 hasAuthorship W2166789524A5069119732 @default.
• W2166789524 hasAuthorship W2166789524A5077841286 @default.
• W2166789524 hasAuthorship W2166789524A5081418650 @default.
• W2166789524 hasConcept C126322002 @default.
• W2166789524 hasConcept C164705383 @default.
• W2166789524 hasConcept C168563851 @default.
• W2166789524 hasConcept C177713679 @default.
• W2166789524 hasConcept C2776301958 @default.
• W2166789524 hasConcept C2777028646 @default.
• W2166789524 hasConcept C2777698277 @default.
• W2166789524 hasConcept C2777849778 @default.
• W2166789524 hasConcept C2778905298 @default.
• W2166789524 hasConcept C2779161974 @default.
• W2166789524 hasConcept C2780890252 @default.
• W2166789524 hasConcept C500558357 @default.
• W2166789524 hasConcept C535046627 @default.
• W2166789524 hasConcept C71924100 @default.
• W2166789524 hasConceptScore W2166789524C126322002 @default.
• W2166789524 hasConceptScore W2166789524C164705383 @default.
• W2166789524 hasConceptScore W2166789524C168563851 @default.
• W2166789524 hasConceptScore W2166789524C177713679 @default.
• W2166789524 hasConceptScore W2166789524C2776301958 @default.
• W2166789524 hasConceptScore W2166789524C2777028646 @default.
• W2166789524 hasConceptScore W2166789524C2777698277 @default.

• next